TIANJIN TEDA BIOMEDICAL ENGINEERING CO.,LTD is a high-tech holding company which is the first publicity in the overseas stock market of Tianjin Binhai New Area, and TEDA, while the Company is also the first pharm-medical engineering company listed in Hongkong Growth Enterprise Market (GEM).

TEDA Biomedical was established in Sept. 2000, invested by 5 units including TEDA Incubation Center, with registered capital of 30 million RMB among which contributions of TEDA Incubation Center is 63.75%, Shuangyou Technology 2.5%, Professor Gu Hanqing, Professor Yang Fusheng, Professor Wu Xiaofang contributing as individuals. The Company now has two sub-companies, Tianjin Alpha Health Care Products Co., Ltd. and Tianjin Wantai Biotechnology Development Co., Ltd. and in 2001, the sales of the Company exceeded 25 million RMB.
Tianjin Alpha Health Care Products Co., Ltd is mainly engaged in the developing, producing food for diabetes, which is regarded as the "High and New Technology Enterprise" by TEDA, and the major products of the Company is qualified as the "National Level New Product", as well the "Tianjin Torch Plan Project".

Tianjin Waitai Biotechnology Development Co., Ltd. is mainly engaged in biotech materials products, series products of electric physiological instrument and treatment instrument. Currently, the major products of the Company include: synthetic crystal, hyaluronic acid sodium, medical pipe material, blood purification equipment, patient monitor products, sleeping monitor products, Ambulatory blood pressure SAS diagnosis system, mattress style SAS diagnosis, RICU 99 system, diabetes treatment instrument etc.